More about
Denosumab
News
April 23, 2019
13 min read
Save
‘Pathbreaking’ osteoporosis therapy offers new option, but treatment challenges remain

The therapeutic arsenal for osteoporosis has expanded dramatically since the early 1980s, when the only options were estrogen for women and calcium and vitamin D for men. Today, the picture is much different. Available therapies include estrogen, raloxifene, four different bisphosphonates, the anabolics teriparatide and abaloparatide, and the monoclonal antibody denosumab.